Simon He

1.6k total citations · 1 hit paper
14 papers, 846 citations indexed

About

Simon He is a scholar working on Genetics, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Simon He has authored 14 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Hematology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Simon He's work include Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Simon He is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Simon He collaborates with scholars based in Australia, United States and United Kingdom. Simon He's co-authors include Andrew W. Roberts, Dennis Carney, Sari H. Enschede, Jennifer R. Brown, Yue Cui, Andrew Krivoshik, Hao Xiong, Rod Humerickhouse, John F. Seymour and Todd Busman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Simon He

13 papers receiving 838 citations

Hit Papers

Substantial Susceptibility of Chronic Lymphocytic Leukemi... 2011 2026 2016 2021 2011 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
    2011 632 citations Andrew W. Roberts, John F. Seymour et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon He Australia 9 470 259 251 245 209 14 846
Michele S. Redell United States 18 562 1.2× 315 1.2× 117 0.5× 402 1.6× 203 1.0× 50 1.1k
Paweł Robak Poland 19 539 1.1× 410 1.6× 343 1.4× 372 1.5× 186 0.9× 86 1.1k
Milada S. Vala United States 14 349 0.7× 437 1.7× 177 0.7× 261 1.1× 208 1.0× 20 860
Anna Korycka Poland 17 304 0.6× 162 0.6× 338 1.3× 114 0.5× 114 0.5× 51 781
C. Vasselon France 11 625 1.3× 420 1.6× 139 0.6× 273 1.1× 127 0.6× 27 964
Valérie Méresse France 13 314 0.7× 218 0.8× 133 0.5× 335 1.4× 117 0.6× 23 830
JP Magaud France 11 713 1.5× 323 1.2× 218 0.9× 500 2.0× 191 0.9× 20 1.3k
Herbert Eradat United States 17 255 0.5× 181 0.7× 564 2.2× 257 1.0× 270 1.3× 60 966
Beth Fischer United States 9 298 0.6× 158 0.6× 426 1.7× 328 1.3× 161 0.8× 28 829
Chetasi Talati United States 16 512 1.1× 592 2.3× 326 1.3× 247 1.0× 80 0.4× 78 1.1k

Countries citing papers authored by Simon He

Since Specialization
Citations

This map shows the geographic impact of Simon He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon He more than expected).

Fields of papers citing papers by Simon He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon He. The network helps show where Simon He may publish in the future.

Co-authorship network of co-authors of Simon He

This figure shows the co-authorship network connecting the top 25 collaborators of Simon He. A scholar is included among the top collaborators of Simon He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon He. Simon He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ardalan, Zaid, Sujievvan Chandran, Abhinav Vasudevan, et al.. (2019). Management of Patients With Erythropoietic Protoporphyria–Related Progressive Liver Disease. Liver Transplantation. 25(11). 1620–1633. 11 indexed citations
2.
Schwarer, Anthony P., Jason Butler, Kathryn Jackson, et al.. (2018). A Comparison of High‐Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML. HemaSphere. 2(6). e158–e158. 2 indexed citations
3.
4.
Wong, Eric, Masa Lasica, Simon He, et al.. (2016). Nephrotic syndrome as a complication of chronic graft‐versus‐host disease after allogeneic haemopoietic stem cell transplantation. Internal Medicine Journal. 46(6). 737–741. 13 indexed citations
5.
He, Simon, et al.. (2016). Hyposplenic changes and pseudo‐Pelger–Huët anomaly following allogeneic stem cell transplantation. British Journal of Haematology. 176(2). 155–155.
6.
7.
Busfield, Samantha J., Mark Biondo, Hayley S. Ramshaw, et al.. (2014). Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC. Leukemia. 28(11). 2213–2221. 106 indexed citations
8.
9.
Busfield, Samantha J., Mark Biondo, Hayley S. Ramshaw, et al.. (2012). CSL362: A Monoclonal Antibody to Human Interleukin-3 Receptor (CD123), Optimized for NK Cell-Mediated Cytotoxicity of AML Stem Cells. Blood. 120(21). 3598–3598. 10 indexed citations
10.
Roberts, Andrew W., John F. Seymour, Jennifer R. Brown, et al.. (2011). Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease. Journal of Clinical Oncology. 30(5). 488–496. 632 indexed citations breakdown →
11.
Khaw, Seong Lin, David C.S. Huang, Simon He, et al.. (2009). Biomarkers and In Vivo Responses to the BH3 Mimetic, ABT-263, in Patients (pts) with Chronic Lymphocytic Leukemia (CLL).. Blood. 114(22). 2374–2374. 2 indexed citations
12.
He, Simon, et al.. (2009). Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia. American Journal of Hematology. 84(11). 715–719. 16 indexed citations
13.
Roberts, Andrew W., Simon He, Kenneth F. Bradstock, et al.. (2008). A Phase 1 and Correlative Biological Study of CSL360 (anti-CD123 mAb) in AML. Blood. 112(11). 2956–2956. 16 indexed citations
14.
Hashimoto, Tomoki, Hiroo Ikehira, Haruki Fukuda, et al.. (1991). In vivo sodium-23 MRI in brain tumors: evaluation of preliminary clinical experience.. PubMed. 6(2). 74–80. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michele S. Redell Breakdown of academic impact, for papers by Paweł Robak Breakdown of academic impact, for papers by Milada S. Vala Breakdown of academic impact, for papers by Anna Korycka Breakdown of academic impact, for papers by C. Vasselon Breakdown of academic impact, for papers by Valérie Méresse Breakdown of academic impact, for papers by JP Magaud Breakdown of academic impact, for papers by Herbert Eradat Breakdown of academic impact, for papers by Beth Fischer Breakdown of academic impact, for papers by Chetasi Talati
Rankless by CCL
2026